I hope to be back in CTIX sometime around the end of the

New Post Public Reply Private Reply Replies (2) Message Board
petemantx
I hope to be back in CTIX sometime around the end of the year as all trials seem to be progressing excellently and things should start popping IMO about that time as to share price. I still follow this board and IHUB regularly to keep apprised of ongoing developments.

I stay in touch with Kelt regularly and his recent surgery came out great and it looks like he is now cancer free. Last week he was still in bed and limited in sitting up and moving about but he said that is passing and within 10 days or so from now he should be pretty well along the road to recovery. He thanks everyone for your prayers.

OT: The stocks I went into, SPIHF and XXII, are now primed for major moves thru the end of the year and you may want to put them on your radar.
SPIHF - Sphere 3D - cloud computing/storage
This stock is to it's field what CTIX should be to medicine. Has that great of potential but differs from CTIX in that their product is now fully tested and vetted and is being aggressively marketed as we speak. Read IHUB post 6160 on the SPIHF board to see feedback from the AGM yesterday in Toronto. They should be uplisted to NASDQ within 2 weeks and by the end of the year revenues should be $200MM+ with potential of over $1B. Currently at about $8.50 and could be double digits within days and high double digits in a heartbeat. Again, the R&D is done, everything in place, and marketing is developing so rapidly they can't keep up with the calls they are getting from the "Big Boys" in business. Their main problem per upper mgt is prioritizing the opportunities. Just signed a major deal with Ericcson. Please, do some rapid DD and keep this on your radar if you have monies to invest over the next couple of months. Kicker is the float is extremely small and there is about a 2MM short position that is going to create a massive squeeze. Example: NOVARAD - leader in medical photos (cat scans, MRI's, etc) needed a solution so that any medical photo could be viewed on any device using any operating system and any application so each photo would be at the highest resolution. Only Sphere's Glassware 2.0 can do that. NOVARAD saw a demo of Glassware and within 60 days put out a product, NOVAGLASS, that addressed their problem and are now actively selling NOVAGLASS with great results. 60 days to integrate Glassware into their product and this is the ease Glassware can go into any product. Can't even begin to explain the myriad applications in health care, govt, large data users, and this is worldwide thru a sales force of 16K agents based on their recent acquisition of Overland Storage/Tandberg Storage.

XXII - Tobacco, MJ?, and plant modification (NOT GMO!) Went from .70 last Aug to $6.50 this Mar and crashed back to $2.40 upon uplisting to NYSE Mkt in Mid-Mar due to overzealous investor runup, MM games, and govt delay in receiving MSA (license to produce tobacco products in the USA). Everything done, trip already concluded with top Chinese state tobacco co. officials, and rollout due this summer that should really get it going. Long term excellent play for dividend stock once your CTIX pays off and you need a place to dump your money for fantastic returns. Not nearly as hot right now as SPIHF.

If this info helps anyone, great, if not, sorry to have cluttered up the board.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Flux Expands AI Platform to Prove Engineering ROI

Updated Category News Views 5

Navigating the AI Maze: Flux's New Pathways Ever feel like these engineering platforms speak a language of their own? Flux's latest expansion finally offers a translator that matters. It's all about decoding whether your AI investment is delivering the goods. Engineering leaders now have more than just fluffy metrics; Flux breaks down real code-based evidence to show if...

Continue Reading
RunVermont Revamps City Marathon, Adds Half for 2027

Updated Category News Views 2

Straight outta Burlington, the M&T Bank Vermont City Marathon is giving its course a facelift and, get this, throwing a half marathon into the mix for 2027. It's about time they shook things up, considering how this race is supposed to be one of the most welcoming on the block. I mean, you're talking about a marathon that's practically been the crown jewel of Vermont's...

Continue Reading
SureDone's Taska AI: Transforming Marketplace Listings

Updated Category News Views 3

Revolutionizing the E-Commerce Landscape Wake up and smell the innovation, folks! SureDone is rolling out Taska AI, a tool that's set to declutter the chaotic world of enterprise marketplace listings. It's no bed of roses for sellers out there, dealing with diverse channel demands and post-submission hiccups. Taska AI steps in as the seasoned handyman these sellers...

Continue Reading
Epiclay: Game Changer for Sculptors Debuts

Updated Category News Views 4

Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...

Continue Reading
Foodsmart's Program Links Food Benefits to Health Gains

Updated Category News Views 2

Navigating the healthcare maze isn't for the faint of heart, especially when it comes to making sure that dollars spent on food benefits actually translate to improved health. Enter Foodsmart, the foodcare powerhouse that just rolled out its Food-is-Medicine Benefits Management (FBM) program. Turning Meals into Measurable Metrics Health plans are under mounting pressure...

Continue Reading
Hi-Tech's Dubai Chocolate Adds Flavor to Sales Surge

Updated Category News Views 3

Ever found a protein shake that tastes like a candy bar from the future? Well, Hi-Tech Pharmaceuticals is banking on their new Dubai Chocolate flavor to hit that sweet spot. This isn't your typical powdered shake game; Hi-Tech's been cranking the flavor dial ever since they introduced their Precision Protein® line back in 2016. They've carved out a niche with unique...

Continue Reading
IWP and SHARE Forge New Path for Filmmaker Funding

Updated Category News Views 2

Revolutionizing Film Financing The film industry has always been a tough nut to crack. Imagine trying to keep your creative baby yours without surrendering the crown jewels of intellectual property. Well, now, the cavalry with a fresh game plan has arrived, and both investors and filmmakers might be ready for another round. This isn't the typical PR fairytale; it's...

Continue Reading
SACHEU Partners with AI to Harness Real Customer Insights

Updated Category News Views 3

Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...

Continue Reading
Oracle Harnesses AI to Streamline Healthcare Payments

Updated Category News Views 4

Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...

Continue Reading
First Lady Steals NYSE Show, Investors Eye Stakes

Updated Category News Views 2

Something's Buzzing at the Big Board Walk over to Wall Street on September 23rd, and guess what you get? A lot more than just stock tickers blinking away. First Lady Melania Trump’s stealing the show at the New York Stock Exchange to kick off the inaugural IMPERIA Summit. She’s there to sound the opening bell and lead the charge in a summit that's focused on the...

Continue Reading

Top 5 Most Recently Viewed Articles

Projected Growth of the Medical Devices Market Exceeds $905 Billion

Updated Category News Views 229

Overview of the Medical Devices Market The global medical devices market is on a promising trajectory, anticipated to exceed US$ 905.56 billion by the year 2033 from a valuation of US$ 517.86 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.4% throughout the forecast period. This remarkable growth is largely influenced by various factors such as...

Continue Reading
Class Action Lawsuit Update for Agenus Inc. (NASDAQ: AGEN)

Updated Category News Views 37

Agenus Inc. Faces Class Action Lawsuit: Key Details for Investors Investors in Agenus Inc. are currently facing critical news regarding a class action securities lawsuit. This legal action has been initiated by Levi & Korsinsky, LLP, a firm that specializes in representing investors in cases related to securities litigation. The company, identified by the stock ticker...

Continue Reading
G6 Networks Unveils GSX Token, Paving the Way for Blockchain Innovation

Updated Category News Views 90

G6 Networks Unleashes GSX Token for Blockchain Transformation G6 Networks has made a remarkable advancement in the blockchain sector with the launch of its GSX token. This initiative promises to pave the way for greater transparency and accessibility within the blockchain community. Offered at a competitive price of $0.85 per token, the three-tier structured launch is...

Continue Reading
Revolutionizing Weight Loss: ASC47 and Semaglutide Study Results

Updated Category News Views 250

ASC47 and Semaglutide: A Promising Combination for Weight Loss Ascletis Pharma Inc. has unveiled exciting findings regarding its weight loss medication, ASC47, particularly when paired with Semaglutide. Participants suffering from obesity showed significantly improved outcomes with this innovative combination therapy, demonstrating a greater reduction in body weight...

Continue Reading
Reviva Pharmaceuticals Secures $10 Million Through Public Offering

Updated Category News Views 187

Reviva Pharmaceuticals Secures Funding for Advancement Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), a dedicated late-stage pharmaceutical company, is making significant strides in the development of innovative therapies aimed at addressing critical needs in the realms of central nervous system (CNS), inflammatory, and cardiometabolic diseases. Recently, Reviva...

Continue Reading